Literature DB >> 15718249

NOD1 variation, immunoglobulin E and asthma.

Pirro Hysi1, Michael Kabesch, Miriam F Moffatt, Michaela Schedel, David Carr, Youming Zhang, Brenda Boardman, Erika von Mutius, Stephan K Weiland, Wolfgang Leupold, Christian Fritzsch, Norman Klopp, A William Musk, Alan James, Gabriel Nunez, Naohiro Inohara, William O C Cookson.   

Abstract

Asthma is a familial inflammatory disease of the airways of the lung. Microbial exposures in childhood protect against asthma through unknown mechanisms. The innate immune system is able to identify microbial components through a variety of pattern-recognition receptors (PRRs). NOD1 is an intracellular PRR that initiates inflammation in response to bacterial diaminopimelic acid (iE-DAP). The NOD1 gene is on chromosome 7p14, in a region that has been genetically linked to asthma. We carried out a systematic search for polymorphism in the gene. We found an insertion-deletion polymorphism (ND(1)+32656) near the beginning of intron IX that accounted for approximately 7% of the variation in IgE in two panels of families (P<0.0005 in each). Allele*2 (the insertion) was associated with high IgE levels. The same allele was strongly associated with asthma in an independent study of 600 asthmatic children and 1194 super-normal controls [odds ratio (OR) 6.3; 95% confidence interval (CI) 1.4-28.3, dominant model]. Differential binding of the two ND(1)+32656 alleles was observed to a protein from nuclei of the Calu 3 epithelial cell line. In an accompanying study, the deletion allele (ND(1)+32656*1) was found to be associated with inflammatory bowel disease. The results indicate that intracellular recognition of specific bacterial products affects the presence of childhood asthma.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15718249     DOI: 10.1093/hmg/ddi087

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  85 in total

Review 1.  Inhibition of pattern recognition receptor-mediated inflammation by bioactive phytochemicals.

Authors:  Ling Zhao; Joo Y Lee; Daniel H Hwang
Journal:  Nutr Rev       Date:  2011-06       Impact factor: 7.110

2.  NOD-like receptors and RIG-I-like receptors in human eosinophils: activation by NOD1 and NOD2 agonists.

Authors:  Anne Månsson Kvarnhammar; Terese Petterson; Lars-Olaf Cardell
Journal:  Immunology       Date:  2011-11       Impact factor: 7.397

Review 3.  Novel susceptibility genes in inflammatory bowel disease.

Authors:  Colin Noble; Elaine Nimmo; Daniel Gaya; Richard K Russell; Jack Satsangi
Journal:  World J Gastroenterol       Date:  2006-04-07       Impact factor: 5.742

Review 4.  Innate immune responses to environmental allergens.

Authors:  Henk F Kauffman
Journal:  Clin Rev Allergy Immunol       Date:  2006-04       Impact factor: 8.667

5.  Purification, crystallization and preliminary crystallographic characterization of the caspase-recruitment domain of human Nod1.

Authors:  Thiagarajan Srimathi; Sheila L Robbins; Rachel L Dubas; Jang Hoon Seo; Young Chul Park
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2006-12-16

6.  No association between the functional CARD4 insertion/deletion polymorphism and inflammatory bowel diseases in the German population.

Authors:  A Franke; A Ruether; N Wedemeyer; T H Karlsen; A Nebel; S Schreiber
Journal:  Gut       Date:  2006-11       Impact factor: 23.059

7.  Influence of a nucleotide oligomerization domain 1 (NOD1) polymorphism and NOD2 mutant alleles on Crohn's disease phenotype.

Authors:  Elisabet Cantó; Elena Ricart; David Busquets; David Monfort; Esther García-Planella; Dolors González; Joaquim Balanzó; José-L Rodriguez-Sanchez; Sílvia Vidal
Journal:  World J Gastroenterol       Date:  2007-11-07       Impact factor: 5.742

Review 8.  The Nodosome: Nod1 and Nod2 control bacterial infections and inflammation.

Authors:  Ivan Tattoli; Leonardo H Travassos; Leticia A Carneiro; Joao G Magalhaes; Stephen E Girardin
Journal:  Semin Immunopathol       Date:  2007-08-10       Impact factor: 9.623

Review 9.  Unleashing the therapeutic potential of NOD-like receptors.

Authors:  Kaoru Geddes; João G Magalhães; Stephen E Girardin
Journal:  Nat Rev Drug Discov       Date:  2009-06       Impact factor: 84.694

10.  The expression and function of Nod-like receptors in neutrophils.

Authors:  Anna-Karin Ekman; Lars Olaf Cardell
Journal:  Immunology       Date:  2009-12-02       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.